COVID-19 Immunisation Program - February 2021 - Victorian Council of Social ...
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
COVID-19 Immunisation Program
February 2021
OFFICIAL: Sensitive
Three pillars of COVID-19 vaccine program
Access for all Highest levels of Public trust and
Victorians safety and quality confidence
Vaccines are free Vaccination sites are supported by Public information and messaging
comprehensive clinical safety and is clear, credible, consistent and
Easy to access for all eligible quality procedures easy to access
Victorians during each phase
Vaccination workforce is Broad and sustained engagement
Equitable access across appropriately trained and with stakeholders across sectors,
geography, social and cultural supervised community and government
groups
Data systems in place to underpin Local engagement activities
Services are appropriate for the monitoring, analysis and reporting enable information flow via
populations they are serving of safety, quality and adverse established professional and
events community networks
Workforce availability is sufficient
to maintain services Specialist services will manage
adverse events following
immunisation
OFFICIAL: Sensitive
Roles and Responsibilities
Victorian
Commonwealth Vaccine Centers
Government
Secure and purchase vaccines Commission and support Establish vaccine centers, outreach
establishment of vaccine clinics, and mobile models to administer
Approve vaccines (TGA) outreach and mobile models vaccines
Allocate, deliver and track vaccine Workforce identification and Manage vaccine product appropriately
products regulatory approval to minimise waste
Fund General Practice, pharmacy Setting state-based policy positions Complete reporting requirements to
and ACCHO sectors and approaches AIR and into CVMS
National booking system planned Monitor and ensure safety and quality, Report adverse events through
(delayed) manage adverse events existing pathways
Commission and oversee Provision of COVID vaccine Work with DH to communicate with
vaccination of private residential management system (CVMS) priority cohorts and the community to
aged and disability staff and create and manage demand
residents Communicate and engage at a state
level Establish Specialist Immunisation
Partner with jurisdictions to enable Services
localisation and scale up
OFFICIAL: SensitiveVaccine characteristics and approvals
Temperature
Vaccine Details Trial Phase Safety Results Efficacy Results TGA Approval
Requirements
Frozen for
storage/transport: Administration well
-70°C ± 10°C for up to 10 tolerated; very few serious
mRNA vaccine 95% efficacy
days unopened Phase 3 results to be safety concerns Provisional approval
(consistent across age,
Thawed: 3 – 5 days at published observed. 25 January 2021
US/Germany sex, ethnicity)
refrigerated 2-8°C Caution with history of
conditions anaphylaxis.
Access
Viral vector vaccine Phase 3 interim results Administration well
Routine refrigerated cold
published in The Lancet tolerated; no serious Pooled efficacy = 70.4% Provisional Determination
chain at 2-8°C
UK (8 December 2020) safety concerns observed
Protein vaccine
Phase 3 trials ongoing in Administration well Pre-publication early
N/A US and Mexico, complete tolerated; no serious release statement N/A
US (clinical trial in
in UK safety concerns observed 89% efficacy
Australia)
OFFICIAL: SensitiveDoses, deliveries, requirements
Purchase Agreement Weekly Deliveries (Victoria) Minimum Delivery
Approximately 1000 doses (one tray) for
~ 11,000 from late February, doubling for use in 3-5 days once thawed, has
10 million doses spread across year
second dose 3-4 weeks after that maximum freeze times once left the
factory
53.8 million doses across the year Expected to be up to 250,000 per week at
TBA
3.8 million imported maximum
Access
50 million local manufacturing*
50 million doses spread across the year TBA TBA
*No confirmation that local manufacturing of AstraZeneca has commenced, noting delays in the Netherlands/Belgian manufacturing facilities have been confirmed last week.
OFFICIAL: SensitivePredicted rollout phases (supply dependent)
The vaccination program is scalable over
time to respond to supply of different
products
Victoria will build capacity rapidly in the
early phases to enable rapid reach in the
crucial Autumn period, and while usual
Access
care pathways (e.g. GP and pharmacy)
are being established
Will leverage existing capacity and
capability in health service, community
health and local government to rapidly
establish and expand access
OFFICIAL: SensitivePredicted rollout phases (supply dependent)
P h a s e 1 a - up to 1.4m doses ONGOING
Quarantine and P h a s e 1 b - up to 14.8m doses
70,000
border workers
Adults aged 80 years
1,045,000
and over P h a s e 2 a - up to 15.8m doses
Frontline health care Adults aged
1,858,000
worker sub-groups 100,000 70-79 years
for prioritisation
Adults aged 60-69
years
2,650,000 P h a s e 2 b - up to 16m doses
Other health care
953,000
workers
P h a s e 3 - up
Aboriginal and Torres Adults aged 50-59
Aged care and 3,080,000 to 13.6m doses
Access
318,000 Strait Islander 87,000 years
disability care staff people > 55 years Balance of adult
6,643,000
population
Younger adults with an Aboriginal and
underlying medical Torres Strait Islander 387,000
2,000,000
Aged care and condition, including people 18- 54
disability care 190,000 those with a disability
residents < 18 if
Critical and high risk Other critical and 5,670,000
453,000 recommended
workers including high risk workers Catch up any
defense, police, fire, 196,000 unvaccinated
emergency services Australians from
Total 678,000 and meat processing previous phases
Total 6,570,000
Total 6,139,000
Source – Australian Government Population numbers are current estimates for each category.
OFFICIAL: SensitiveHospital Hubs – to commence February 22
Purpose of Hospital Hubs (referred to by the Commonwealth as ‘Pfizer Hubs’)
• 9 hospital hubs aligned to Victoria’s Local Public Health Units will commence Victoria’s COVID-19 vaccine rollout and will be the delivery point for the
Pfizer vaccine into Victoria.
• Metropolitan – Western Health, Austin Health, Monash Health
• Regional – Barwon Health, Goulburn Valley Health, Latrobe Health, Bendigo Health, Ballarat Health, Albury-Wodonga Health
• The primary purpose is to achieve rapid and early coverage of several priority cohorts in phases 1a and 1b.
• Hubs will also play an important role in designing Victorian based models, and training staff to work in other models.
Target Cohort Projected Outputs
ACCCESS
Primarily targeted 1a and 1b cohorts in the first instance, with focus on health Primary vehicle for distribution of Victoria’s Pfizer allocation, likely to be
care workers, public sector residential aged care ~11,000 per week for first 3 weeks, doubling thereafter to allow for
second doses
Delivery Model Commencement and Duration
Large fixed clinics at or adjacent to large public hospitals affiliated with Proposed readiness for commencement from 22 Feb 2021, to continue
LPHUs. Outreach to HQ and PoE sites, outreach to other health services, throughout 2021 or until product is no longer available
PSRACs
Proposed State Government Support
Provision of funding to support infrastructure establishment, initial staff training, access to surge workforce
Co-design of Pfizer Hubs Guidelines and SOPs
Requirement to use Victoria’s CVMS
OFFICIAL: SensitiveCOVID vaccine delivery models
Hospital COVID Vaccine
Hubs Clinics
Community Health Victoria’s High Volume
ACCCESS
Vaccine Network COVID Vaccine Centres
Vaccine
System
COVID Vaccine General Practice,
Teams (CVTs) ACCHOs, other
OFFICIAL: SensitiveFoundations for communications, engagement and
partnerships
GOAL DRIVEN SYSTEM-ORIENTED
The program exists within, rather than in isolation
COVID Immunisation Program is one element
of, the broader service system.
of Victoria’s comprehensive pandemic
response. The vaccine is not a ‘panacea’, offering Engagement seeks to mobilise all sector partners
an immediate return to normal life. through a systems approach.
Public trust and confidence
Engagement must be clearly linked to the intent of
the national program and continue to reflect the
international evidence base.
RESPONSIVE INTEGRATED
The COVID Immunisation Program is integral to
Vaccine hesitancy is a spectrum and may
the broader state-wide COVID-19 prevention and
be experienced by ~20% of the general
preparedness response.
population.
Engagement will build on longstanding community
Engagement must be responsive to individual
assets and capabilities, and COVID-19 specific
and community attitudes; it does not presume
community engagement activity.
unquestioning acceptance.
OFFICIAL: SensitiveCommunications to achieve universal
and targeted reach
Website Social media Traditional media Campaign Direct engagement
coronavirus.vic.gov.au/vaccines DH/COVID Response Rapid response to queries Victorian Government Regular engagement
Twitter and Facebook and misinformation; ongoing campaign (social, media, with stakeholders both
CHO Twitter proactive media digital, outdoor advertising within Government and
opportunities etc) external
Public trust and confidence
Single source of truth that DHHS twitter has 182,000 Mainstream media A campaign is being Use existing and new
will be updated regularly followers and DHHS continues to be primary developed for Victoria. It networks to share
Facebook has 180,000 source of information for is expected this will messages
Dedicated pages for followers. Reach of social Victorians primarily focus on and communications
stakeholders (health care, media posts is often motivating target cohorts collateral – ensure a
aged care etc) millions of people (mid Regular updates on roll consistent message
Dec – mid Jan 66 million out incorporated into daily Commonwealth across WoVG
Data hub that provides media releases Government is running a
people).
updates on the vaccine National Campaign – Build relationships with
roll out Regular Timely issues focused on general external stakeholders
science explainers management to counter population and some and seek opportunities to
misinformation targeted cohorts amplify messages
Graphics and videos to
support explainers Media events and Source intelligence and
proactive stories advice from
stakeholders
OFFICIAL: SensitiveDiversifying engagement approaches
CALD DH Industry LGA Communications Immunisation
Working groups
advisory groups Contact / PoE and Engagement workforce
teams
Establish and work with Partnerships with local Clear communication, Current preliminary Leverage Councils’ strong Ensure that current
existing working groups. organisations that can collaboration and trust are forums and internal (DH channels to reach out to workforce is supported
Ensuring these structures rapidly provide essential to the rollout of or whole of Vic Govt) local communities. Ensure in both vaccine and
Public trust and confidence
run effectively is a key culturally appropriate the Vaccine program working group meetings all communities have COVID safe messages
determinant to success. material and services. accessible information
Many working Work with existing Dedicated email Many working Capture insights Work with key
groups already channels to address to be groups exist., monthly to networks and
exist. We will utilise determine at risk monitored and including: determine new and agencies to
these groups to community members measured Department of emerging barriers to determine any gaps
share and update on through the following Transport, Dept vaccination. in knowledge,
the Vaccine rollout networks. CALD Public facing Hotline Jobs, Precincts & content and material
program. Taskforce, Health and clinical contact Regions, for both the
Advisory Panel, centre Commercial workforce and
Capture insights DPC, DJPR, LGAs, Passenger Vehicles community.
weekly to determine Area Managers, Vic.
new and emerging Divisions.
barriers to We will utilise these
vaccination. groups to share and
update on the
Vaccine rollout
program.
OFFICIAL: SensitiveYou can also read
